TiumBio Co., Ltd. (KOSDAQ:321550)
South Korea flag South Korea · Delayed Price · Currency is KRW
12,220
+220 (1.83%)
At close: Apr 28, 2026

TiumBio Revenue

In the year 2025, TiumBio had annual revenue of 12.29B KRW with 80.92% growth. TiumBio had revenue of 4.45B in the quarter ending December 31, 2025, with 200.09% growth.

Revenue
12.29B
Revenue Growth
+80.92%
P/S Ratio
29.80
Revenue / Employee
n/a
Employees
n/a
Market Cap
366.19B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202512.29B5.50B80.92%
Dec 31, 20246.79B1.89B38.65%
Dec 31, 20234.90B-4.22B-46.27%
Dec 31, 20229.12B9.06B15,952.75%
Dec 31, 202156.80M-992.15M-94.59%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
NIBEC 32.72B
Bio Solution 15.20B
curacle co.,ltd. 7.10M
Y-Biologics 2.91B
Kangstem Biotech 3.57B
ViGenCell 278.95M
ABION 880.14M
S.Biomedics 16.55B
Revenue Rankings